Drug Trial Radar · NCT01726452
NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)
Last checked: Nov 20, 2026Latest source record: Sep 30, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
377
Actual
Start
Jan 24, 2013
Primary completion
Aug 4, 2022
Study completion Aug 4, 2022
Sponsor
- Lead sponsor
- Cancer Trials IrelandResearch network
- Sponsor type
- Research network
- Collaborators
- Southampton Clinical Trials Unit; Copenhagen University Hospital, Rigshospitalet; Centre Hospitalier Régional, Universitaire de Lille
- First posted
- Nov 15, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicentre phase III open-labelled, randomised controlled trial. Eligible patients will be randomised in a 1:1 fashion between neoadjuvant and adjuvant chemotherapy (Investigator's choice modified MAGIC (ECF/ECX or EOF/EOX) or FLOT regimen) and surgery or Arm B (CROSS protocol: chemotherapy with radiation therapy and surgery as per multimodal protocol). Primary Objective: To evaluate one, two and three year survival of patients treated with resection plus neoadjuvant and adjuvant chemotherapy versus resection plus neoadjuvant chemo radiotherapy. Secondary Objective(s): To evaluate the effect of both neoadjuvant regimens on clinical and pathological response rate (in particular relief of dysphagia, improvement in health related quality of life (HRQL), endoscopic regression, and CT-PET evidence of tumour response), tumour regression grade, node-positivity, post-operative pathology, disease-free survival, time to treatment failure, toxicity, post-operative complications and Health Related Quality of Life (HRQL). Exploratory Objective(s): Translational Research: The collection of blood and tissue samples for storage in the bio bank for future research.
Conditions
- Adenocarcinoma of the Oesophagus
- Adenocarcinoma of the Oesophago-gastric Junction
- Oesophageal Tumours
- Junctional Tumours
- Oesophageal Cancer
Interventions
EpirubicinDrug
50mg/m2 on Day 1 of each cycle only (i.e. every 21 days)
Cisplatin / OxaliplatinDrug
Cisplatin, 60mg/m2 on day 1 of each cycle only (i.e. every 21 days). OR Oxaliplatin,130 mg/m2 on Day 1 of each cycle (i.e. every 21 days) The choice between administering Cisplatin or Oxaliplatin is at the discretion of the investigator.
5 Flourouracil/ CapecitabineDrug
5-Flourouracil 200 mg/m2/day every day for 21 days OR Capecitabine 625 mg/m2 twice daily orally). The choice between administering 5 Flourouracil or Capecitabine is at the discretion of the investigator.
(41.4 Gy/23 fractions)Radiation
Patient will receive 4.5 weeks of radiation therapy (41.4 Gy/23 fractions).
PaclitaxelDrug
50mg/ m2 Paclitaxel dose administered on Days 1, 8, 15,22 and 29. Dexamethasone, Chlorphenamine and Ranitidine dose given per local standard practice. NACL infusion per local standard practice. Ondansetron dose given per local standard practice on Days 1, 8, 15, 22 and 29.
CarboplatinDrug
Dose determined as per calculation, infused on Days 1, 8, 15, 22 and 29
DocetaxelDrug
Docetaxel, 50 mg/m², day 1 of each cycle (i.e. every 14 days)
OxaliplatinDrug
85 mg/m², day 1 of each cycle (i.e. every 14 days)
LeucovorinDrug
200 mg/m², day 1 of each cycle (i.e. every 14 days).
5-FluorouracilDrug
2600 mg/m² Day 1 of each cycle (i.e. every 14 days) Dexamethasone or equivalent, 8mg, twice daily, Day before, day of and day after OR administered as per standard practice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall survivalTime frame: At end of trial- up to 3 years in follow up
Locations
29 sites in 5 countries. Site status is shown where the registry gives one.
Rigshospitalet
Blegdamsvej 9, Denmark
Centre Hospitalier Régional, Universitaire de Lille 2 Avenue Oscar Lambret, 59000
Lille, France
Cork University Hospital
Cork, Ireland
Beaumont Hospital
Dublin, Ireland
SLRON- St Luke's Radiation Oncology Network
Dublin, Ireland
St. James's Hospital
Dublin, Ireland
University Hospital Galway
Galway, Ireland
Karolinska Institutet and Karolinska University Hospital
Stockholm, Sweden
Belfast Health and Social Care Trust, Northern Ireland Cancer Centre, Belfast CityHospital
Belfast, United Kingdom
The Clatterbridge Cancer Centre NHS Foundation Trust
Birkenhead, Wirral, United Kingdom
University Hospitals Bristol NHS Foundation Trust
Bristol, United Kingdom
University Hospital Plymouth NHS Trust
Derriford Hospital, Derriford Road, Crownhill, Plymouth, United Kingdom
NHS Lothian, Edinburgh Cancer Centre,
Edinburgh, United Kingdom
Beatson West of Scotland Cancer Centre
Glasgow, 1056 Great Western Road, United Kingdom
Imperial College Healthcare NHS Trust St Mary's Hospital
London, United Kingdom
The Newcastle upon Tyne Hospital NHS Foundation TrustFreeman Hospital, Freeman Road, High Heaton
Newcastle upon Tyne, United Kingdom
Royal Preston Hospital
Sharoe Garoo Lane, Fulwood, Preston, United Kingdom
The Royal Bournemouth Hospital
The Royal Bournemouth and Christchurch Hospitals NHS Foundation, Bournemouth, United Kingdom
Cambridge University Hospitals NHS Foundation Trust
Addenbrooke's Hospital, Box 279(s4), Cambridge Biomedical Camp, Cambridge, United Kingdom
Velindre Cancer Centre
Velindre NHS Trust, Velindre Road, Whitchurch, Cardiff, United Kingdom
University Hospitals Coventry & Warwickshire
Clifford Bridge Road, Walsgrave, Coventry, United Kingdom
Hull and East Yorkshire Hospitals NHS Trust, Castle Hill Hospital,
Cottingham, East Riding Of Yorkshire, United Kingdom
Portsmouth Hospitals NHS Trust
Southwick Hill Road, Cosham, Hampshire, United Kingdom
Mount Vernon Cancer Centre
E & N Hertfordshire NHS Trust, Rickmansworth Road, Northwood, Middlesex, United Kingdom
Nottingham City Hospital
Nottingham University Hospitals NHS Trust, Hucknall Road, Nottingham, United Kingdom
Oxford University Hospital NHS Trust Churchill Hospital
Headington, Oxfordshire, United Kingdom
University Hospital Southampton NHS Foundation Trust
Southampton General Hospital, Division A Cancer Care, Mp307, T, Southampton, United Kingdom
Royal Surrey County Hospital
Guildford, Surrey, United Kingdom
Worcestershire Royal Hospital
Worcestershire Oncology Centre, Charles Hastings Way, Worcester, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.